Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992–2001

Author(s):  
Maaike A. van der Aa ◽  
Eltjo M.J. Schutter ◽  
Monika Looijen-Salamon ◽  
Jolise E. Martens ◽  
Sabine Siesling
2016 ◽  
Vol 19 (7) ◽  
pp. A416-A417
Author(s):  
D Setiawan ◽  
Q Cao ◽  
TA Westra ◽  
MJ Postma

2000 ◽  
Vol 30 (1) ◽  
pp. 35-42 ◽  
Author(s):  
Rosella P.M.G. Hermens ◽  
Margot A.J.B. Tacken ◽  
Marlies E.J.L. Hulscher ◽  
Jozé C.C. Braspenning ◽  
Richard P.T.M. Grol

2000 ◽  
Vol 4 (4) ◽  
pp. 208-211 ◽  
Author(s):  
Stewart L. Massad ◽  
Helen E. Cejtin ◽  
Nadeem R. Abu-Rustum

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Raquel Ibáñez ◽  
María Alejo ◽  
Neus Combalia ◽  
Xavier Tarroch ◽  
Josefina Autonell ◽  
...  

Objective. Audit of women with invasive cervical cancer (CC) is critical for quality control within screening activities. We analysed the screening history in the 10 years preceding the study entry in women with and without CC during 2000–2011.Methods. 323 women with CC from six pathology departments in Catalonia (Spain) and 23,782 women with negative cytology were compared. Age, previous history of cytologies, and histological type and FIGO stage were collected from the pathology registries. Logistic regression analysis was used to estimate odds ratios (OR) and 95% confidence intervals (CI95%).Results. History of cytology was registered in 26.2% of CC cases and in 78% of the control women (P<0.0001) and its frequency decreased with increasing age. Compared to women with squamous cell carcinoma, adenocarcinoma cases were significantly more likely to have a cytology within the 3-year interval preceding cancer diagnosis (OR=2.6CI 95%: 1.2–5.6) and to have normal cytology results in previous screenings (OR=2.4CI 95%: 1.2–4.5). FIGO II–IV cases were more common among older women (older than 60 years).Conclusions. Absence of prior screening history was extremely common among CC cases compared to controls. Organized actions to reduce underscreened women and use of highly sensitive HPV-based tests could be important to reduce CC burden.


Sign in / Sign up

Export Citation Format

Share Document